Keyphrases
Acute Psychosis
8%
Admission Rate
7%
Akathisia
24%
Alternative Learning
8%
Antipsychotics
15%
Anxiety Disorders
11%
Bipolar Disorder
5%
Bruxism
9%
Clomipramine
10%
Clozapine
9%
Cognitive Behavioral Group Therapy
10%
Cognitive Behavioral Therapy
6%
Comorbid
5%
Control Subjects
6%
Corneal Temperature
9%
Drug-free
14%
Electroconvulsive Therapy
5%
Fluvoxamine
6%
Haloperidol
8%
Healthy Controls
8%
Israel
14%
Israeli
11%
Liebowitz Social Anxiety Scale
6%
Major Depressive Disorder
8%
Malignant Hyperthermia
6%
Mental Disorders
6%
Neuroleptic Malignant Syndrome
24%
Obsessive-compulsive
15%
Obsessive-compulsive Disorder
100%
Obsessive-compulsive Symptoms
8%
Orbitofrontal Cortex
9%
Patients with Schizophrenia
14%
Platelets
9%
Polymorphism
5%
Propranolol
9%
Psychosis
7%
Psychotic
9%
Risk Factors
5%
Schizophrenia
38%
Schizophrenia Spectrum Disorders
6%
Schizophrenic Patients
50%
Selective Serotonin Reuptake Inhibitors
6%
Serum Creatine Kinase
12%
Sexual Behavior
6%
Sexual Dysfunction
5%
Social Anxiety
11%
Social Anxiety Disorder
34%
Social Phobia
32%
Social Rank
6%
Symptom Severity
5%
Neuroscience
Acute Psychosis
9%
Akathisia
15%
Anxiety Disorder
8%
Behavior (Neuroscience)
24%
Bipolar Disorder
7%
Bruxism
9%
Clomipramine
9%
Clozapine
10%
Compulsive Behavior
6%
Creatine Kinase
14%
Dementia Praecox
51%
Electroconvulsive Therapy
5%
Major Depressive Disorder
5%
Mental Disorder
6%
Neuroleptic Malignant Syndrome
9%
Obsessive-Compulsive Disorder
69%
Orbitofrontal Cortex
9%
Platelet
9%
Propranolol
10%
Psychosis
6%
Selective Serotonin Reuptake Inhibitor
5%
Social Anxiety Disorder
35%
Typical Antipsychotic
38%
